Microbiology Culture growing at a CAGR of 9.16% from 2025 to 2033
The global microbiology culture market size was estimated at USD 10.25 billion in 2024 and is projected to reach USD 22.33 billion by 2033, growing at a CAGR of 9.16% from 2025 to 2033. The market growth is primarily driven by factors such as the rising prevalence of infectious diseases, increasing demand for rapid diagnostic solutions, and the growing adoption of advanced microbiological techniques in clinical, pharmaceutical, and research laboratories.
Key Market Trends & Insights
- The North America microbiology culture industry held the largest share of 38.27% of the global market in 2024.
- The microbiology culture industry in the U.S. is expected to grow significantly over the forecast period.
- By product, the culture media segment held the largest market share of 53.03% in 2024.
- Based on application, the pharmaceutical & biopharmaceutical production segment held the largest market share in 2024.
- By type, the bacterial segment held the largest market share in 2024.
Market Size & Forecast
- 2024 Market Size: USD 10.25 Billion
- 2033 Projected Market Size: USD 22.33 Billion
- CAGR (2025-2033): 9.16%
- North America: Largest market in 2024
- Asia Pacific: Fastest growing market
Request Free Sample Report: https://www.grandviewresearch.com/industry-analysis/microbiology-culture-market-report/request/rs1
Advancements in microbiology techniques
Advances in microbial practices have notably accelerated the growth of the global microbiology culture industry. The traditional culture practice has received more interplay with automation, increased speed, specimen throughput systems, and molecular microbiology instruments, allowing laboratory users to culture and process larger volumes of more specific sample types. In addition, automated culture systems lessen human error, improve repeatability, and ease workflows in collecting complex clinical, research, and industry quality tests, accelerating usability. The technical growth aspect alone has made culture-based diagnostics quicker, more reliable, and accessible, further supporting the growth of high-quality culture media worldwide.
Market Concentration & Characteristics
The degree of innovation in the microbiology culture industry is a key factor driving its growth. Companies are continuously developing advanced culture media, selective and differential formulations, and automated systems that enhance microbial detection speed, accuracy, and reliability. Integrating digital technologies, high-throughput screening, and molecular diagnostics allows laboratories to obtain faster results while reducing human error.
Mergers and acquisitions (M&A) activity is a key market force in the microbiology culture industry, with companies looking to bolster product portfolios, expand geographically, and gain technological know-how. Larger companies often acquire smaller specialized companies to create access to innovative culture media technologies, diagnostic solutions, and smaller segments of specialized market niches. M&A activity helps to develop a company’s R&D capabilities to scale production and better access emerging regions. For example, in September 2025, bioMérieux acquired Brazil-based Neoprospecta and its DNA sequencing and genomics platform to enhance microbiological data analytics for quality assurance and contamination prevention in Latin America.
Microbiology Culture Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 11.08 billion |
|
Revenue forecast in 2033 |
USD 22.33 billion |
|
Growth rate |
CAGR of 9.16% from 2025 to 2033 |
|
Base year for estimation |
2024 |
|
Historical data |
2021 – 2023 |
|
Forecast period |
2025 – 2033 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2033 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Product, type, application, region |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
|
Country scope |
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; India; China; Japan; Australia; South Korea; Thailand; Brazil; Argentina; Saudi Arabia; UAE; South Africa; Kuwait |
|
Key companies profiled |
Thermo Fisher Scientific Inc.; Merck KGaA; bioMérieux SA; BD; Bio-Rad Laboratories, Inc.; Neogen Corporation; HiMedia Laboratories; Hardy Diagnostics; Amerigo Scientific |
|
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |